Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

GH Guardant Health Inc

30,44

-0,93 (-2,96%)

27 Dez 2024 - Fechado

Atrasado em 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

The shares sold in this filing were acquired and paid for between 03/15/2024 and 11/15/2024.

Date of Notice

12/13/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

09/11/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Musa Tariq

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024

Click aqui para mais gráficos Guardant Health.

Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024

Click aqui para mais gráficos Guardant Health.

Notícias Guardant Health Inc

Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care
Sexta, 20 de Dezembro de 2024 (1 semana atrás) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Quinta, 19 de Dezembro de 2024 (1 semana atrás) • Edgar (US Regulatory)

COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
Quinta, 19 de Dezembro de 2024 (1 semana atrás) • Business Wire

Form 144 - Report of proposed sale of securities
Quarta, 18 de Dezembro de 2024 (1 semana atrás) • Edgar (US Regulatory)

Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
Quarta, 18 de Dezembro de 2024 (2 semanas atrás) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Segunda, 16 de Dezembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Segunda, 16 de Dezembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Segunda, 16 de Dezembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Segunda, 16 de Dezembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Segunda, 16 de Dezembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Sexta, 13 de Dezembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium
Segunda, 9 de Dezembro de 2024 (3 semanas atrás) • Business Wire

Mais Notícias de Guardant Health Inc

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições